Xspray seeking FDA approval for oral CML treatment XS003
Xspray Pharma has submitted an application to the…
Blood cancer
Blood cancer overview
Blood cancer is a broad term encompassing diseases in which blood cells grow too much or develop abnormally. Typically, blood cancers are classified into three main categories – leukemia, lymphoma, and myeloma – but they can be further divided into dozens of specific types, each with unique features.
Read moreTreatments for blood cancers
A wide range of therapies are available for treating blood cancer, from chemotherapy and targeted therapy to radiation, stem cell transplant, and surgery. When devising a suitable treatment plan for blood cancer, healthcare providers take into account various factors, such as age, overall health, the specific type of blood cancer, and potential treatment side effects.
Read moreLatest news
Blood cancer therapy SGR-2921 discontinued after patient deaths
Biotech company Schrödinger said it’s discontinuing the development…
FDA fast tracks birelentinib for certain hard-to-treat blood cancers
The U.S. Food and Drug Administration (FDA) granted fast…
Scemblix now OK’d in Canada for treating newly diagnosed CML
More people in Canada with the rare …
Aucatzyl approved in Europe for relapsed/refractory B-ALL
The European Commission has approved Autolus Therapeutics’ cell…
AML treatment ICT01 granted FDA’s orphan drug status
ICT01, an immune-modulating therapy being developed by Imcheck…
